Skip to main content

Table 2 Anti-Zika virus immunoglobulin M and G levels of 13 participants with neutralizing antibodies to Zika virus epidemic) (N = 879)

From: Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey

 

ELISA results

Neutralizing antibody titer (PRNT50)

Neutralizing antibody titer (PRNT90)

Sample ID

ZIKV IgM(P/N ratio)

DENV IgM(Index Value)

Anti-ZIKV

NS1 IgG (P/N ratio)

ZIKV

DENV-1

DENV-2

DENV-3

DENV-4

ZIKV

DENV-1

DENV-2

DENV-3

DENV-4

During epidemic (January 2017)

Z120aa

3.3

0.1

2.2

160

320

320

< 20

< 20

< 20

320

80

< 20

< 20

Z140a

2.3

0.3

4.7a

80

40

320

< 20

< 20

< 20

< 20

40

< 20

< 20

Z141a

4.9

0.1

3.4

640

160

80

< 20

< 20

40

80

< 20

< 20

< 20

Z153ab

2.8

0.3

3.2

160

< 20

< 20

< 20

< 20

40

< 20

< 20

< 20

< 20

Z476a

4.7

0.5

43.9a

640

320

1280

20

< 20

80

320

160

< 20

< 20

Z735a

2.8

0.6

8.1

320

< 80

< 80

< 80

< 80

80

< 80

< 80

< 80

< 80

Z147aa

1.6

ND

4.5

320

80

160

20

40

80

< 20

80

< 20

< 20

Z472a

1.5

ND

46.1

5120

160

160

80

40

640

80

40

80

< 20

Z606a

1.6

ND

10.6

1280

< 20

< 20

< 20

< 20

160

< 20

< 20

< 20

< 20

Z138a

4.6

0.6

0.9

40

320

80

< 20

< 20

< 20

160

< 20

< 20

< 20

Z420ab

3.7

0.1

0.2

160

160

160

20

< 20

20

20

40

< 20

< 20

Z587a

1.2

ND

0.2

320

640

640

1280

160

80

320

320

640

20

Z591a

1.2

ND

0.6

640

640

640

1280

80

80

320

160

640

< 20

Post-epidemic (July 2018)

Z120ba

ND

ND

2.3

80

640

160

1280

20

20

320

40

320

< 20

Z140b

ND

ND

5.2

640

< 20

160

< 20

20

20

< 20

80

< 20

< 20

Z141b

ND

ND

2.7

640

160

20

160

< 20

80

80

< 20

40

< 20

Z476b

ND

ND

4.7

2560

320

320

320

80

160

80

80

160

< 20

Z735b

ND

ND

3.5

80

320

80

320

80

< 20

320

20

160

20

Z138b

ND

ND

0.5

80

40

< 20

40

< 20

< 20

20

< 20

20

< 20

  1. DENV dengue virus, DENV1–4 dengue virus serotypes 1–4, ELISA enzyme-linked immunosorbent assay, IgG immunoglobulin G, IgM immunoglobulin M, N negative, ND not detected, P positive, PRNT50 plaque-reduction neutralization test with neutralization defined as ≥50% reduction in challenge virus plaque-forming units, PRNT90 plaque-reduction neutralization test with neutralization defined as ≥90% reduction in challenge virus plaque-forming units, ZIKV Zika virus
  2. Figures in bold indicate positive results.a ZIKV antibodies were determined using anti-ZIKV NS1 IgG ELISA (P/N ratio ≥ 2). b Z153 and Z420 were not available during the post endemic collection